Sharon Smith

A genome-wide AI model prioritizes three genetic variants linked to postoperative sepsis and outlines how preoperative genotyping could support targeted monitoring strategies. Medscape News Europe source https://www.medscape.com/viewarticle/ai-identifies-three-predictive-variants-postoperative-sepsis-2026a10006mo?src=rss

A new GLP-1 drug showed superior efficacy in reducing A1c and weight in patients with T2D. Medscape Medical News source https://www.medscape.com/viewarticle/new-oral-glp-1-beats-oral-semaglutide-a1c-weight-loss-2026a10006jd?src=rss

While first-ever guidelines are in the works, experts across specialties share their take on the current state of preventing, diagnosing, and managing CKM syndrome. Medscape Medical News source https://www.medscape.com/viewarticle/interdisciplinary-focus-ckm-syndrome-gains-traction-2026a10006j6?src=rss

In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and alters epigenetic age signals after allergen or diesel exhaust exposure. Medscape Medical News source https://www.medscape.com/viewarticle/does-budesonide-shield-against-air-pollution-rhinitis-2026a10006bp?src=rss

Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and up to 7 days with refrigeration. Medscape Medical News source https://www.medscape.com/viewarticle/compounded-lidocaine-plus-epinephrine-remains-safe-and-2026a10006bk?src=rss

GLP-1s sometimes cause unpleasant side effects that can lead to nonadherence and discontinuation, but some patients stay the course anyway. What factors motivate them not to give up? Medscape Medical News source https://www.medscape.com/viewarticle/what-boosts-adherence-glp-1s-2026a100066e?src=rss